Lunai Bioworks Inc (LNAI) Stock Price, Quote & News

Company Profile

Lunai Bioworks Inc., a pre-clinical stage biotechnology company, provides medicine, diagnostics, and biodefense products the United States and the Netherlands. It operates through three segments, RENB, BioSymetrics, and RENC. The company is developing a genetically modified allogeneic dendritic cell therapeutic vaccines, including RENB-DC11 to treat solid tumors primarily for pancreatic tumors; and RENB-DC20 for the treatment of breast cancer. It also develops an artificial intelligence platform...

Industry: Biotechnology

Sector: Healthcare

Phone: 305 918 1980

Website: www.lunaibioworks.com

Address:

2080 Century Park East, Suite 906, Los Angeles, United States

Stock__Hunter Dec. 4 at 7:29 PM

$LNAI In our book, there all dil. scams. Learn to play poker then

0 · Reply

Stock__Hunter Dec. 4 at 7:23 PM

$LNAI 2 db bottoms 50ma slowly pushing it down. 1 pr sends this on our list

0 · Reply

MarketForecasting Dec. 4 at 1:45 PM

$LNAI why would they need this toxic dilution if there set to see revenue from there business ? Bc it is all a hoax , a lie , they have zero products to offer . It is a scam . File reports with the sec is my advice .

0 · Reply

DonDon531 Dec. 3 at 5:24 PM

$LNAI

0 · Reply

MarketForecasting Dec. 3 at 3:53 PM

$LNAI the level of scam this company is involved in is appalling

1 · Reply

stockwuzet Dec. 3 at 12:19 PM

$LNAI https://www.sec.gov/ix?doc=/Archives/edgar/data/0001527728/000173112225001625/e7056_8-k.htm

0 · Reply

stockwuzet Dec. 3 at 12:18 PM

$LNAI https://www.sec.gov/Archives/edgar/data/1527728/000173112225001626/e7057_424b5.htm

0 · Reply

Waxer Dec. 2 at 8:07 AM

$LNAI Overnight is $1.35. Setting up for a good week

0 · Reply

eponski Dec. 1 at 10:13 PM

$LNAI

0 · Reply

stockwuzet Dec. 1 at 8:57 PM

$LNAI https://www.sec.gov/Archives/edgar/data/1527728/000121465925017353/xslSCHEDULE_13D_X01/primary_doc.xml

1 · Reply

Lunai Bioworks Secures First Licensing LOI Following Landmark Breakthrough Showing Complete Tumor Regression in Humanized Cancer Models

Nov 5, 2025, 9:22 AM EST - 4 weeks ago

Lunai Bioworks achieves complete regression of both primary and metastatic pancreatic tumors in preclinical humanized models, marking a breakthrough in allogeneic cancer immunotherapy

Oct 30, 2025, 9:32 AM EDT - 5 weeks ago

Lunai Bioworks Harnesses AI and Zebrafish Data to Advance Early Detection of Neurotoxic Compounds

Oct 16, 2025, 9:45 AM EDT - 7 weeks ago

Landmark Study Identifies Prognostic Biomarkers in Duchenne Muscular Dystrophy Using Large-Scale Serum Proteomics

Oct 16, 2025, 9:15 AM EDT - 7 weeks ago

Lunai Bioworks Regains Compliance with Nasdaq Minimum Bid Price Requirement

Oct 6, 2025, 9:15 AM EDT - 2 months ago

Lunai Bioworks Launches AI-Powered Alzheimer's Disease Program, Expanding Neurodegenerative Pipeline

Sep 30, 2025, 9:15 AM EDT - 2 months ago

Lunai Bioworks Unveils New Corporate Identity, Streamlined Capital Structure, and Strategic Focus on AI-Powered Therapeutics and Biodefense

Sep 25, 2025, 8:30 AM EDT - 2 months ago

Lunai Bioworks Advances Biomarker Discovery Preclinical Program in Parkinson's Disease, Positioning for Strategic Pharma Partnerships

Sep 24, 2025, 4:50 PM EDT - 2 months ago

Lunai Bioworks, Inc. to Effect 10:1 Reverse Stock Split

Sep 11, 2025, 7:00 AM EDT - 3 months ago

Lunai Bioworks subsidiary BioSymetrics and Brigham and Women's Hospital Awarded NIH STTR Grant to Develop AI-Powered Platform for Alcohol Use Disorder Therapeutics

Sep 9, 2025, 9:12 AM EDT - 3 months ago

Top 3 Health Care Stocks You'll Regret Missing In Q3

SMMT

Sep 9, 2025, 8:47 AM EDT - 3 months ago

Lunai Bioworks Inc. Unveils Transformer Platform to Secure Generative AI and Accelerate Drug Discovery

Sep 8, 2025, 8:50 AM EDT - 3 months ago

Lunai Bioworks Strengthens European Strategy Through Restructuring

Sep 4, 2025, 10:05 AM EDT - 3 months ago

Lunai Bioworks Inc. Retains American Defense International

Aug 27, 2025, 9:45 AM EDT - 3 months ago

Renovaro Inc. Announces Corporate Name Change to Lunai Bioworks, Inc., Reflecting Strategic Focus on AI-Driven Biodefense, Drug Discovery and Advanced Diagnostics

Aug 8, 2025, 10:45 AM EDT - 4 months ago

Renovaro Inc. (NASDAQ: RENB) Mentioned in RealClearDefense Article on AI and Biodefense Risks

Jul 28, 2025, 10:38 AM EDT - 4 months ago

Renovaro Secures Key AI Patents, Strengthening Market Position in $20B Biomedical AI Sector

Jul 17, 2025, 9:15 AM EDT - 5 months ago

Peer-Reviewed Study Validates Renovaro's Genetically Engineered Dendritic Cell Therapy with Potent Anti-Tumor Efficacy

Jul 9, 2025, 8:00 AM EDT - 5 months ago

Renovaro Strengthens Balance Sheet Through Debt Conversion and Advances AI-Driven Initiatives

Jun 30, 2025, 9:21 AM EDT - 5 months ago

Renovaro Launches AI-Based Neurotoxin Countermeasure Initiative Addressing Emerging National Security Needs

Jun 3, 2025, 9:15 AM EDT - 6 months ago

Renovaro Secures Key U.S. Patent to Strengthen AI-Driven Drug Discovery and Diagnostics Platform

May 22, 2025, 3:12 PM EDT - 7 months ago

UPDATE - Renovaro Inc. Announces Expedited Trial for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology

May 22, 2025, 11:05 AM EDT - 7 months ago

Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology

May 14, 2025, 9:15 AM EDT - 7 months ago

Renovaro Launches Augusta, an AI-Powered Precision Neurology Platform

May 13, 2025, 9:15 AM EDT - 7 months ago

Renovaro and Amsterdam University Medical Center Announce Exclusive Collaboration to Advance Blood Platelet RNA Diagnostics

Apr 22, 2025, 9:20 AM EDT - 8 months ago

Renovaro Secures High-Powered Computing from Nebul Through a Partnership to Accelerate Next-Generation Biomarker Discovery and Diagnostic Programs

Apr 9, 2025, 9:25 AM EDT - 8 months ago

Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine

Apr 4, 2025, 9:40 AM EDT - 8 months ago

Renovaro Provides Update to Definitive Agreement with Predictive Oncology

Mar 3, 2025, 9:15 AM EST - 9 months ago

Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology

Feb 26, 2025, 1:25 PM EST - 10 months ago

Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine

Feb 26, 2025, 9:15 AM EST - 10 months ago

Renovaro Announces $15 million in Equity Committed

Jan 7, 2025, 6:51 PM EST - 11 months ago

PREDICTIVE ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc. - POAI

POAI

Jan 7, 2025, 9:15 AM EST - 11 months ago

Renovaro Appoints Nathen Fuentes as Chief Financial Officer

Jan 7, 2025, 9:15 AM EST - 11 months ago

Renovaro Issues Shareholder Letter and Provides Corporate Update

Jan 6, 2025, 9:15 AM EST - 11 months ago

Renovaro to Acquire Predictive Oncology in All-Stock Transaction

Dec 30, 2024, 9:00 AM EST - 1 year ago

Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV

Dec 23, 2024, 9:00 AM EST - 1 year ago

RenovaroCube Receives Approval of Lumina Project by the Eurostars Funding Program

Dec 20, 2024, 3:40 PM EST - 1 year ago

Renovaro Regains Compliance with NASDAQ Listing Requirement

Dec 20, 2024, 9:00 AM EST - 1 year ago

Renovaro Enters into a Strategic Collaboration with Nebul to Advance a Paradigm Shift for Early Disease Detection

Oct 17, 2024, 9:15 AM EDT - 1 year ago

RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore Sequencing

Oct 16, 2024, 9:28 AM EDT - 1 year ago

Renovaro Announces Strategic Restructuring and Leadership Transition

Sep 13, 2024, 9:00 AM EDT - 1 year ago

RenovaroCube to Present Cutting-Edge Cancer Diagnostics Research at European Society for Medical Oncology Congress

Sep 11, 2024, 9:15 AM EDT - 1 year ago

RenovaroCube Announces Strategic Offering of Up to 20% Ownership

Jun 14, 2024, 9:06 AM EDT - 1 year ago

Renovaro, Inc. Announces $10 million in Equity Committed

May 24, 2024, 9:20 AM EDT - 1 year ago

Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy

May 21, 2024, 8:39 AM EDT - 1 year ago

Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month - Renovaro (NASDAQ:RENB)

BAX RAPT SAGE TMCI

Apr 30, 2024, 11:00 AM EDT - 1 year ago

Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics

Apr 24, 2024, 9:00 AM EDT - 1 year ago

RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership

Apr 18, 2024, 8:45 AM EDT - 1 year ago

Renovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Mission to Reshape Cancer Screening, Diagnosis, and Patient C

Stock__Hunter Dec. 4 at 7:29 PM

$LNAI In our book, there all dil. scams. Learn to play poker then

0 · Reply

Stock__Hunter Dec. 4 at 7:23 PM

$LNAI 2 db bottoms 50ma slowly pushing it down. 1 pr sends this on our list

0 · Reply

MarketForecasting Dec. 4 at 1:45 PM

0 · Reply

DonDon531 Dec. 3 at 5:24 PM

$LNAI

0 · Reply

MarketForecasting Dec. 3 at 3:53 PM

$LNAI the level of scam this company is involved in is appalling

1 · Reply

stockwuzet Dec. 3 at 12:19 PM

$LNAI https://www.sec.gov/ix?doc=/Archives/edgar/data/0001527728/000173112225001625/e7056_8-k.htm

0 · Reply

stockwuzet Dec. 3 at 12:18 PM

$LNAI https://www.sec.gov/Archives/edgar/data/1527728/000173112225001626/e7057_424b5.htm

0 · Reply

Waxer Dec. 2 at 8:07 AM

$LNAI Overnight is $1.35. Setting up for a good week

0 · Reply

eponski Dec. 1 at 10:13 PM

$LNAI

0 · Reply

stockwuzet Dec. 1 at 8:57 PM

$LNAI https://www.sec.gov/Archives/edgar/data/1527728/000121465925017353/xslSCHEDULE_13D_X01/primary_doc.xml

1 · Reply

everythingsok Dec. 1 at 7:18 PM

$LNAI

0 · Reply

crabhunter Dec. 1 at 6:58 PM

$LNAI back to wednesday's late action.... juuuuust maybe.

0 · Reply

Waxer Dec. 1 at 6:44 PM

$LNAI

0 · Reply

rrc2007 Dec. 1 at 6:36 PM

$LNAI This is a good one.

0 · Reply

apersonwhowishes Dec. 1 at 5:10 PM

$CAPS Is there anyone who can kill 0.9225? $CTM $LNAI

0 · Reply

11thestate Dec. 1 at 3:35 PM

$LNAI has reached a 2.5M settlement with $ENOB investors over claims that it concealed its co-founder’s lack of proper credentials and criminal history. The filing deadline is December 7, 2025. If you bought $ENOB between January 17, 2018 and June 27, 2022, you can file for payment here: https://11th.com/cases/enochian-biosciences-investor-settlement

0 · Reply

rrc2007 Dec. 1 at 2:15 PM

$LNAI

0 · Reply